Kolon TissueGene Market Cap

Kolon TissueGene has a market cap or net worth of 6.28 trillion as of January 16, 2026. Its market cap has increased by 225.38% in one year.

Market Cap

6.28T

Enterprise Value

6.24T

Revenue

5.08B

Ranking

n/a

PE Ratio

n/a

Stock Price

75,500.00

Market Cap Chart

Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 6.28T, an increase of 143.70%. That is a compound annual growth rate of 11.46%.

Market Cap History

Date	Market Cap	% Change
Jan 19, 2026	6.28T	-5.15%
Dec 30, 2025	6.62T	258.54%
Dec 30, 2024	1.85T	181.73%
Dec 28, 2023	655.80B	7.08%
Dec 29, 2022	612.43B	-76.74%
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Nov 6, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	88.92T
Celltrion	45.18T
ALTEOGEN	26.53T
ABL Bio	10.89T
SK Biopharmaceuticals	9.26T
Yuhan	7.91T
HLB Co., Ltd.	6.83T
Sam Chun Dang Pharm.	6.43T

Market Cap Rankings